Are antihypertensive drugs associated with an increased risk of incident type 2 diabetes?
Pantelis A Sarafidis* and George L Bakris
Correspondence *Hypertension/Clinical Research Center, Department of Preventive Medicine, Rush University Medical Center, 1700 West Van Buren, Suite 470, Chicago, IL 60612, USA
Email psarafidis11@yahoo.gr
This article has no abstract so we have provided the first paragraph of the full text.
Over the past 25 years, numerous studies have demonstrated a spectrum of effects of the various classes of antihypertensive agents on carbohydrate metabolism. In general, thiazide diuretics and 
-blockers worsen insulin sensitivity and glycemic control, whereas ACE inhibitors, angiotensin II receptor blockers, CCBs, and 
-blockers have neutral or beneficial effects. It must be noted, however, that not all drugs within a given class have similar effects on these parameters. For example, vasodilating -blockers have metabolic effects distinct from those of conventional -blockers.1
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
